104151757
liked
Dear mooers,
We value the importance of the "Markets" tab as a crucial feature for many of our dedicated users looking to invest wisely, and we recognize that the current version may be too complex and difficult to navigate. As a platform committed to constant evolution and user satisfaction, we have taken into account your feedback and are delighted to announce the forthcoming launch of a new and improved "Markets" tab.
So, what can you expect from thi...
We value the importance of the "Markets" tab as a crucial feature for many of our dedicated users looking to invest wisely, and we recognize that the current version may be too complex and difficult to navigate. As a platform committed to constant evolution and user satisfaction, we have taken into account your feedback and are delighted to announce the forthcoming launch of a new and improved "Markets" tab.
So, what can you expect from thi...
![Navigate with ease on the new "Markets" tab](https://ussnsimg.moomoo.com/feed_image/77777004/c244c488873e30968018a755cafef20a.jpg/thumb)
![Navigate with ease on the new "Markets" tab](https://ussnsimg.moomoo.com/77777004/editor_image/954a7508d7a5369999ae40ce7521f584.png/thumb)
![Navigate with ease on the new "Markets" tab](https://ussnsimg.moomoo.com/77777004/editor_image/d5be844384393571823a634a44559d08.jpg/thumb)
+1
51
77
4
104151757
commented on
Gapping up
$Viasat (VSAT.US)$ +5.9% (the Wall Street Journal reported that the satellite company was close to a deal to sell a military communications unit to defense contractor $L3Harris Technologies (LHX.US)$ for nearly $2 billion.)
$Myovant Sciences (MYOV.US)$ +31.3% (the biopharmaceutical company rejected a bid by its largest shareholder, Sumitovant Biopharma, to buy the shares it doesn’t already own for $22.75 per share. Myovant said...
$Viasat (VSAT.US)$ +5.9% (the Wall Street Journal reported that the satellite company was close to a deal to sell a military communications unit to defense contractor $L3Harris Technologies (LHX.US)$ for nearly $2 billion.)
$Myovant Sciences (MYOV.US)$ +31.3% (the biopharmaceutical company rejected a bid by its largest shareholder, Sumitovant Biopharma, to buy the shares it doesn’t already own for $22.75 per share. Myovant said...
![Today's Pre-Market Stock Movers: TSLA, CS, VOD, MYOV and More](https://1400137786.vod2.myqcloud.com/3fdf1d2cvodtransgzp1400137786/b8403ebd387702306750596398/coverBySnapshot/coverBySnapshot_10_0.jpg)
63
16
10
104151757
commented on
Columns My stories on SmartSave
SmartSave allows us to deposit and withdraw idle funds anytime and anywhere, allowing our cash to earn more money while lying idle. This is a feature that I personally value when I opened this account, as my investment strategy dictates that I will be holding cash during certain specific time periods. During these times, the money market fund is my best option. Although the returns it brings may not be high, as a responsible investor, I cannot afford to miss out on such an...
![My stories on SmartSave](https://sgsnsimg.moomoo.com/102905851/editor_image/72576ea385723d09bae6a2182b5eebe1.jpg/thumb)
141
90
14